Yep, it's pretty low and there's almost certainly only a small window of a few months between when a patient progresses on Herceptin and no longer meet the eligibility criteria for the trial. It will likely be compounded by the fact there is only one hospital (in Adelaide) running the trial. I won't be surprised if it runs over but hopefully, they were looking for more sites for this trial while visiting hospitals this week.
IMU Price at posting:
18.5¢ Sentiment: Buy Disclosure: Held
